Theratechnologies Inc. (THTX)

Theratechnologies Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Year Ending	TTM	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Cash & Equivalents	31.17	34.1	23.86	20.4	12.74	28.66
Short-Term Investments	4.86	6.29	9.21	19.96	8.03	11.96
Cash & Cash Equivalents	36.03	40.39	33.07	40.35	20.77	40.63
Cash Growth	42.02%	22.13%	-18.05%	94.31%	-48.88%	-16.56%
Receivables	12.85	13.02	12.05	10.49	12.43	10.12
Inventory	5.53	6.07	19.69	29.14	25.15	20.93
Other Current Assets	2.91	3.82	8.57	11.93	6.46	4.51
Total Current Assets	57.33	63.3	73.37	91.91	64.81	76.18
Property, Plant & Equipment	0.92	1.98	3.09	2.85	3.48	1.07
Long-Term Investments	0	0	0	0	0	0.62
Goodwill and Intangibles	11.78	12.5	15.01	21.39	24.53	27.48
Other Long-Term Assets	0.19	0	1.79	3.06	7.32	12.2
Total Long-Term Assets	12.89	14.47	19.89	27.3	35.34	41.37
Total Assets	70.21	77.77	93.26	119.21	100.14	117.56
Accounts Payable	26.28	28.47	41.07	40.38	34.82	31.17
Deferred Revenue	0.04	0.04	0.04	0.05	0.05	0.07
Current Debt	17.9	7.71	65.27	0.46	0.43	3.42
Other Current Liabilities	7.77	11.08	7.91	4.18	6.63	2.48
Total Current Liabilities	51.98	47.29	114.28	45.08	41.92	37.14
Long-Term Debt	41.42	51.26	1.45	56.28	54.96	55.31
Other Long-Term Liabilities	0.02	0.08	0.11	0.09	0.04	0.27
Total Long-Term Liabilities	41.44	51.35	1.55	56.38	55	55.58
Total Liabilities	93.42	98.64	115.83	101.45	96.92	92.72
Total Debt	59.32	58.97	66.71	56.75	55.38	58.73
Debt Growth	-11.03%	-11.61%	17.56%	2.46%	-5.70%	19.29%
Retained Earnings	-412.15	-408.66	-382.65	-335.25	-300.13	-277.46
Comprehensive Income	0.8	0.68	0.39	-0.04	-0.48	0.02
Shareholders' Equity	-23.21	-20.87	-22.57	17.76	3.22	24.83
Net Cash / Debt	-23.29	-18.58	-33.64	-16.39	-34.62	-18.1
Working Capital	5.34	16	-40.91	46.83	22.89	39.04
Book Value Per Share	-0.51	-0.86	-0.95	0.75	0.17	1.63

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).